Grand Rapids, MI., February 27, 2024 – Virtual Incision, a cultivate(MD) portfolio company, has been granted marketing authorization of the MIRA™ Surgical System (MIRA) from the FDA. This marks a significant milestone as MIRA becomes the first miniaturized robotic-assisted surgery device in the world approved for adult colectomy procedures. The device was submitted via the FDA’s De Novo […]
The spaceMIRA, a groundbreaking surgical robot, embarks on a historic journey to the International Space Station, a collaborative effort involving the University of Nebraska and NASA. Virtual Incision Corporation, part of the cultivate(MD) portfolio and creator of the MIRA Surgical System (MIRA), has announced the departure of its spaceMIRA model to the International Space Station. The spaceMIRA’s
Virtual Incision’s Mini Surgical Robot Heads to Space Read More »
Physics-based STAGE™ quantitative output and ground truth data used with Canon AiCE (Advanced intelligent Clear-IQ Engine) deep learning reconstruction could significantly expand MRI access for neuroimaging BINGHAM FARMS, MI, and TUSTIN, CA, Jan. 16, 2024 – SpinTech MRI, creators of the STAGE™ (STrategically Acquired Gradient Echo) quantitative magnetic resonance imaging (MRI) software platform, and Canon Medical Systems
Grand Rapids, Mich., December 11, 2023 – cultivate(MD), a leader in medical device venture capital, is thrilled to announce that one of its portfolio companies, NSite Medical, has received FDA clearance for its groundbreaking AI-based scoliosis scanning application. This marks a significant milestone in advancing medical technology and offering new, innovative solutions for scoliosis management. NSite
cultivate(MD) Portfolio Company NSite Medical Announces FDA Clearance Read More »
Collaboration will assess operational and clinical impacts of STAGE through an analysis of neuroimaging efficiency, reporting workflows and clinical outcomes in actual cases. BINGHAM FARMS, MI, Nov. 27, 2023 – SpinTech MRI, creators of the STAGE™ (Strategically Acquired Gradient Echo) quantitative magnetic resonance imaging (MRI) software platform, today announced that Yale New Haven Hospital and
SpinTech MRI and Yale New Haven Hospital to Examine Impact of STAGE on MRI Read More »
Grand Rapids, Mich., November 27, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced today that they have made a significant investment into Nanochon, a Washington, D.C.—based regenerative cartilage innovator. Nanochon develops solutions utilized by sports medicine physicians to treat active patients requiring
cultivate(MD) Capital Funds LP Announce Investment into Nanochon Read More »
Grand Rapids, Mich., October 23, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced today that one of their portfolio companies, St. Louis, Missouri-based SentiAR, Inc., a pioneer in using Augmented Reality (AR) visualization technology for cardiac ablation procedures, has received their second
We are thrilled to announce that the INTEGRATE®-C from HAPPE Spine has been recognized among the Best New Spine Technologies of 2023 by Orthopaedics This Week!
INTEGRATE®-C Named to Best New Spine Technologies of 2023 Read More »
Grand Rapids, Mich., September 29, 2023—Shoulder Innovations Inc. (SI), a Grand Rapids, Michigan based leader in the shoulder replacement implant market announced today that they have hired Mr. Jeff Points as Chief Financial Officer. Mr. Points has 25 years of finance experience in high-growth organizations, most recently as Chief Financial Officer at Cardiovascular Systems where he
Shoulder Innovations Announces Placement of New CFO and New VP of Commercial Development Read More »
LINCOLN, Neb.–(BUSINESS WIRE)– Virtual Incision Corporation, the developer of the world’s first miniaturized robotic-assisted surgery (RAS) system, announced a $30 million extension to its previous $46 million Series C financing. The round was led by current investors Bluestem Capital, Endeavour Vision, Baird Capital, cultivate(MD) Capital Funds, and PrairieGold Venture Partners, as well as new health-tech
Virtual Incision Extends Series C Round with Additional $30M Funding Read More »
